| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Emma Fisher, R Andrew Moore, Alexandra E Fogarty, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804836. |
no other beneficial effects were found for other types of cannabinoids, cannabis, or cbm in our primary analyses; 81% of subgroup analyses were negative. |
2021-08-03 |
2023-08-13 |
human |
| Emma Fisher, R Andrew Moore, Alexandra E Fogarty, David P Finn, Nanna B Finnerup, Ian Gilron, Simon Haroutounian, Elliot Krane, Andrew S C Rice, Michael Rowbotham, Mark Wallace, Christopher Ecclesto. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32804836. |
the evidence neither supports nor refutes claims of efficacy and safety for cannabinoids, cannabis, or cbm in the management of pain. |
2021-08-03 |
2023-08-13 |
human |
| Mohammed Mohiuddin, Fiona M Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, Simon Haroutounian, Andrew Moore, Andrew S C Rice, Mark Wallace, Rex Park, Ian Gilro. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32941319. |
general risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews. |
2021-08-03 |
2023-08-13 |
Not clear |
| Mohammed Mohiuddin, Fiona M Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, Simon Haroutounian, Andrew Moore, Andrew S C Rice, Mark Wallace, Rex Park, Ian Gilro. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32941319. |
the growing demand for improved pain treatments together with expanding legalization of, and access to, cannabinoids, cannabis, and cannabis-based medicines has intensified the focus on risk-benefit considerations in pain management. |
2021-08-03 |
2023-08-13 |
Not clear |
| Mohammed Mohiuddin, Fiona M Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, Simon Haroutounian, Andrew Moore, Andrew S C Rice, Mark Wallace, Rex Park, Ian Gilro. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:32941319. |
in the meantime, this evidence should be carefully examined when making risk-benefit considerations about the use of cannabinoids, cannabis, and cannabis-based medicine for chronic pain. |
2021-08-03 |
2023-08-13 |
Not clear |
| Simon Haroutounian, Ian Gilron, Joletta Belton, Louisa Degenhardt, Marta Di Forti, David P Finn, Alexandra Fogarty, Eija Kalso, Elliot Krane, R Andrew Moore, Michael Rowbotham, Mark Wallace, Andrew S C Ric. Societal issues and policy implications related to the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:33009248. |
societal issues and policy implications related to the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. |
2021-08-03 |
2023-08-13 |
Not clear |
| . International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:33729207. |
international association for the study of pain presidential task force on cannabis and cannabinoid analgesia position statement. |
2021-08-03 |
2023-08-13 |
Not clear |
| Andrew S C Rice, Joletta Belton, Lars Arendt Nielse. Presenting the outputs of the IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:33729208. |
presenting the outputs of the iasp presidential task force on cannabis and cannabinoid analgesia. |
2021-08-03 |
2023-08-13 |
Not clear |
| David P Finn, Simon Haroutounian, Andrea G Hohmann, Elliot Krane, Nadia Soliman, Andrew S C Ric. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:33729211. |
this narrative review represents an output from the international association for the study of pain's global task force on the use of cannabis, cannabinoids, and cannabis-based medicines for pain management, informed by our companion systematic review and meta-analysis of preclinical studies in this area. |
2021-08-03 |
2023-08-13 |
Not clear |
| Simon Haroutounian, Lars Arendt-Nielsen, Joletta Belton, Fiona M Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, David P Finn, Nanna B Finnerup, Emma Fisher, Alexandra E Fogarty, Ian Gilron, Andrea G Hohmann, Eija Kalso, Elliot Krane, Mohammed Mohiuddin, R Andrew Moore, Michael Rowbotham, Nadia Soliman, Mark Wallace, Nantthasorn Zinboonyahgoon, Andrew S C Ric. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:34138827. |
international association for the study of pain presidential task force on cannabis and cannabinoid analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. |
2021-08-03 |
2023-08-13 |
Not clear |
| Simon Haroutounian, Lars Arendt-Nielsen, Joletta Belton, Fiona M Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, David P Finn, Nanna B Finnerup, Emma Fisher, Alexandra E Fogarty, Ian Gilron, Andrea G Hohmann, Eija Kalso, Elliot Krane, Mohammed Mohiuddin, R Andrew Moore, Michael Rowbotham, Nadia Soliman, Mark Wallace, Nantthasorn Zinboonyahgoon, Andrew S C Ric. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:34138827. |
the president of the international association for the study of pain established a task force on cannabis and cannabinoid analgesia to systematically examine the evidence on (1) analgesic pharmacology of cannabinoids and preclinical evidence on their efficacy in animal models of injury-related or pathological persistent pain; (2) the clinical efficacy of cannabis, cannabinoids, and cannabis-based medicines for pain; (3) harms related to long-term use of cannabinoids; as well as (4) societal issues and policy implications related to the use of these compounds for pain management. |
2021-08-03 |
2023-08-13 |
Not clear |
| Simon Haroutounian, Lars Arendt-Nielsen, Joletta Belton, Fiona M Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, David P Finn, Nanna B Finnerup, Emma Fisher, Alexandra E Fogarty, Ian Gilron, Andrea G Hohmann, Eija Kalso, Elliot Krane, Mohammed Mohiuddin, R Andrew Moore, Michael Rowbotham, Nadia Soliman, Mark Wallace, Nantthasorn Zinboonyahgoon, Andrew S C Ric. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:34138827. |
we provide recommendations to improve the quality, rigor, transparency, and reproducibility of preclinical and clinical research on cannabis and cannabinoids for pain, as well as for the conduct of systematic reviews on the topic. |
2021-08-03 |
2023-08-13 |
Not clear |
| Simon Haroutounian, Lars Arendt-Nielsen, Joletta Belton, Fiona M Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, David P Finn, Nanna B Finnerup, Emma Fisher, Alexandra E Fogarty, Ian Gilron, Andrea G Hohmann, Eija Kalso, Elliot Krane, Mohammed Mohiuddin, R Andrew Moore, Michael Rowbotham, Nadia Soliman, Mark Wallace, Nantthasorn Zinboonyahgoon, Andrew S C Ric. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain. vol 162. issue Suppl 1. 2021-08-03. PMID:34138827. |
remaining important questions about long-term and short-term safety of cannabis and cannabinoids are emphasized. |
2021-08-03 |
2023-08-13 |
Not clear |
| Bryan Latrell Holloman, Mitzi Nagarkatti, Prakash Nagarkatt. Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases. International journal of molecular sciences. vol 22. issue 14. 2021-08-03. PMID:34298921. |
cannabinoids are a group of compounds produced in the body (endocannabinoids) or found in cannabis (phytocannabinoids) that act through cannabinoid receptors and various other receptors expressed widely in the brain and immune system. |
2021-08-03 |
2023-08-13 |
Not clear |
| Viola Brugnatelli, Enrico Facco, Gastone Zanett. Lifestyle Interventions Improving Cannabinoid Tone During COVID-19 Lockdowns May Enhance Compliance With Preventive Regulations and Decrease Psychophysical Health Complications. Frontiers in psychiatry. vol 12. 2021-08-03. PMID:34335317. |
in this paper, we explore the psychosomatic impact of prolonged quarantine in healthy individuals, and propose management and coping strategies that may improve endocannabinoid tone, such as integration of probiotics, cannabidiol, meditation, and physical exercise interventions with the aim of supporting interpersonal, individual, and professional adherence with covid-19 emergency public measures whilst minimizing their psycho-physical impact. |
2021-08-03 |
2023-08-13 |
human |
| Sivan Shiponi, Nirit Bernstei. The Highs and Lows of P Supply in Medical Cannabis: Effects on Cannabinoids, the Ionome, and Morpho-Physiology. Frontiers in plant science. vol 12. 2021-08-03. PMID:34335641. |
the highs and lows of p supply in medical cannabis: effects on cannabinoids, the ionome, and morpho-physiology. |
2021-08-03 |
2023-08-13 |
Not clear |
| Shiori Takashina, Yuki Igarashi, Miki Takahashi, Yukie Kondo, Koichi Inou. Screening Method for the Quality Evaluation of Cannabidiols in Water-based Products Using Liquid Chromatography Tandem Mass Spectrometry. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry. vol 36. issue 11. 2021-08-02. PMID:32713900. |
a sensitive, useful and preliminary screening method was proposed to quantitate the containable cannabinoids most commonly included in mineral water and gummi candy products, specifically cannabidiol (cbd), cannabinol (cbn), 11-nor-9-carboxy-Δ |
2021-08-02 |
2023-08-13 |
Not clear |
| A J da Silva, E S Dos Santo. Energetic and thermodynamical aspects of the cyclodextrins-cannabidiol complex in aqueous solution: a molecular-dynamics study. European biophysics journal : EBJ. vol 49. issue 7. 2021-08-02. PMID:32939610. |
cyclodextrins (cds) are well-known carriers for encapsulating hydrophobic molecules, while among cannabinoids, cannabidiol (cbd) has attracted considerable attention due to its therapeutic capability. |
2021-08-02 |
2023-08-13 |
Not clear |
| Samer Asmar, Adam Nelson, Tanya Anand, Ahmad Hammad, Omar Obaid, Michael Ditillo, Tawab Saljuqi, Andrew Tang, Bellal Josep. Marijuana and thromboembolic events in geriatric trauma patients: The cannabinoids clots correlation! American journal of surgery. 2021-08-02. PMID:34334193. |
marijuana and thromboembolic events in geriatric trauma patients: the cannabinoids clots correlation! |
2021-08-02 |
2023-08-13 |
Not clear |
| Valeria Giorgi, Daniela Marotto, Alberto Batticciotto, Fabiola Atzeni, Sara Bongiovanni, Piercarlo Sarzi-Puttin. Cannabis and Autoimmunity: Possible Mechanisms of Action. ImmunoTargets and therapy. vol 10. 2021-07-30. PMID:34322454. |
renewed interest in the medicinal properties of cannabis has led to increasing research into the practical uses of cannabis derivatives, and it has been found that the endocannabinoid system (particularly cb2 receptor activation) is a possible target for the treatment of inflammatory and the autoimmune diseases related to immune cell activation. |
2021-07-30 |
2023-08-13 |
human |